The trade threats could reduce exports to the United States and dampen investment in Europe, dealing a blow to growth at a ...

Saudi-based Sudair Pharma Company is set to establish its new insulin plant in the Sudair City for Industry and Businesses.

Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 10 includes Advanced Micro Devices, Novo Nordisk ...